Qube Research & Technologies Ltd - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 106 filers reported holding RAPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$662,191
-67.0%
39,843
-62.8%
0.00%
-71.4%
Q2 2023$2,004,472
+9.7%
107,191
+7.6%
0.01%
-12.5%
Q1 2023$1,827,82599,6090.01%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$53,076,29617.67%
Euclidean Capital LLC 432,900$8,571,4208.02%
GREAT POINT PARTNERS LLC 1,436,569$28,444,0665.58%
KINGDON CAPITAL MANAGEMENT, L.L.C. 880,000$17,424,0003.47%
Trustees of Columbia University in the City of New York 73,383$1,4533.00%
Cheyne Capital Management (UK) LLP 71,828$1,422,1942.48%
Deep Track Capital, LP 1,304,940$25,837,8121.08%
Ghost Tree Capital, LLC 125,000$2,475,0001.06%
Perceptive Advisors 1,798,955$35,619,3091.00%
BRAIDWELL LP 1,000,000$19,800,0000.66%
View complete list of RAPT THERAPEUTICS INC shareholders